Studies found that defects in insulin signaling were selective with a dramatic reduction of insulin-stimulated IRS-PI3K-Akt pathway rather than the MEK/ERK pathway in type 2 diabetic patients [13]. Here, INS is linked to type 2 diabetes mellitus.